The present review ultimately weighs early concerns against increasingly consistent evidence that GLP-1 RA use does not raise overall cancer risk, clarifies that breast cancer risk appears neutral, and further highlights key mechanisms, such as the reduction of hyperinsulinemia and immune-microenvironment modulation, through which these drugs may improve rather than exacerbate malignancy outcomes
For example, certain FTO variants are associated with higher baseline appetite signaling, while specific GLP1R variants may correlate with differences in satiety response
Board pearl: A fast dex load = transient HTN, then hypotension + bradycardia
Others find oral medications less effective for appetite control and prefer to stay on injections
What is heat therapy and hot topical analgesic treatment
For a broader overview of how GLP-1 medications support weight loss, this GLP-1 explainer is a helpful companion read